/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
0
0
raincastle
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
raincastle2021-11-03 15:20:282021-11-08 15:36:30Active RAC1 promotes tumorigenic phenotypes and therapy resistance in solid tumors. Cancers. 2020; 12: 1541
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
0
0
raincastle
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
raincastle2021-11-03 15:20:112021-11-08 15:36:30RAC1 takes the lead in solid tumors. Cells. 2019; 8(5): 382.
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
0
0
raincastle
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
raincastle2021-11-03 15:19:512021-11-08 15:36:30The role of Rac in tumor susceptibility and disease progression: From biochemistry to the clinic. Biochemical Society Transactions. 2018; 46: 1003-1012.
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
0
0
raincastle
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
raincastle2021-11-03 15:19:322021-11-08 15:36:30Targeting Rac and Cdc42 GTPases in cancer. Cancer Res. 2018; 78(12): 3101-3011.
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
0
0
raincastle
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
raincastle2021-11-03 15:19:042021-11-08 15:36:30The Rac GTPase in cancer: From old concepts to new paradigms. Cancer Res. 2017; 77(20): 5445-5451.
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
0
0
raincastle
/wp-content/uploads/2021/10/RP17002-Logo_Final.svg
raincastle2021-11-03 15:18:472021-11-08 15:36:30RAC1: An emerging therapeutic option for targeting cancer angiogenesis and metastasis. Mol Cancer Ther. 2013; 12(10): 1925–34.
